Trial intelligence / Profile preview

MORGAGNI: Optimal Duration of Anticoagulation in DVT

NCT01285661Phase 3Completed

Sponsor
Università di Padova
Start
Mar 2010
Primary completion
Oct 2015
Countries
1
01

Overview

A Phase 3 trial of warfarin in deep vein thrombosis (DVT), sponsored by Università di Padova. Started Mar 2010; status: completed.

02

Drugs

warfarin
03

Conditions

deep vein thrombosis (DVT)

Beyond the preview

Go deeper on NCT01285661.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01285661.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call